Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
46,407,177
-
Share change
-
+10,473,043
-
Total reported value
-
$278,292,363
-
Put/Call ratio
-
8.9%
-
Price per share
-
$6.00
-
Number of holders
-
64
-
Value change
-
+$62,519,881
-
Number of buys
-
46
-
Number of sells
-
19
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q3 2020
As of 30 Sep 2020,
Aptose Biosciences Inc. - Common Shares was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,407,177 shares.
The largest 10 holders included
Consonance Capital Management LP, Nantahala Capital Management, LLC, DRW Securities, LLC, PICTET ASSET MANAGEMENT LTD, Corriente Advisors, LLC, Point72 Asset Management, L.P., Polar Capital LLP, Opaleye Management Inc., Woodline Partners LP, and CITADEL ADVISORS LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.